High SARS-CoV-2 seroprevalence in Karaganda, Kazakhstan before the launch of COVID-19 vaccination

COVID-19 exposure in Central Asia appears underestimated and SARS-CoV-2 seroprevalence data are urgently needed to inform ongoing vaccination efforts and other strategies to mitigate the regional pandemic. Here, in a pilot serologic study we assessed the prevalence of SARS-CoV-2 antibody-mediated im...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadyrova, Irina, Yegorov, Sergey, Negmetzhanov, Baurzhan, Kolesnikova, Yevgeniya, Kolesnichenko, Svetlana, Korshukov, Ilya, Akhmaltdinova, Lyudmila, Vazenmiller, Dmitriy, Stupina, Yelena, Kabildina, Naylya, Ashimova, Assem, Raimbekova, Aigul, Turmukhambetova, Anar, Miller, Matthew S., Hortelano, Gonzalo, Babenko, Dmitriy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328563/
https://www.ncbi.nlm.nih.gov/pubmed/35895743
http://dx.doi.org/10.1371/journal.pone.0272008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328563/
https://www.ncbi.nlm.nih.gov/pubmed/35895743
http://dx.doi.org/10.1371/journal.pone.0272008

Ejemplares similares